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Immunohistochemical studies on the peritoneal membrane and infil.
trating cells in normal subjects and in patients on CAPD. We performed
immunohistochemical studies on biopsies of the parietal peritoneal mem-
brane of 33 subjects to investigate whether other cell populations, in
addition to mononuclear cells free in the dialysate, might participate in the
defense of the peritoneum against microbial invasion during CAPD.
Leukocytes were found to concentrate in two areas: a submesothelial layer
composed of elongated macrophages displaying activation and maturation
markers, and perivascular, less mature macrophages closely associated
with T cells and HLA-DR, ICAM-1 and VCAM-1 expressing endothelial
cells. Normal mesothelial cells were found to express constitutively the
transferrin receptor and the adhesion molecules ICAM-1 and VCAM-1
but not ELAM-1. There were no major differences between normal and
uremic subjects, while peritoneal dialysis patients exhibited minor de-
rangements of the submesothelial layer and slight up-regulation of the
expression of HLA-DR on endothelial cells. Peritonitis was associated
with increased submesothelial cellularity and, particularly, perivascular
leukocyte infiltration accompanied by increased expression of HLA-DR
and adhesion molecules. Besides mononuclear cells free in the dialysate,
this study demonstrates the existence of two additional peritoneal mem-
brane leukocyte populations: submesothelial macrophages, and perivas-
cular macrophages and T cells. It also suggests the existence of a fourth
population of intracavitary leukocytes adherent to mesothelial cells.
Studies are now necessary to evaluate their exact role in the host defence
against peritonitis during CAPD.
Fifteen years after its introduction, continuous ambulatory
peritoneal dialysis (CAPD) is now used world-wide for the
treatment of patients with end-stage renal disease [1]. Familiarity
with the method and technical developments have lessened, but
not eliminated, episodes of contamination of the peritoneal cavity
resulting in clinical peritonitis and associated morbidity [2—4].
Phagocytosis performed by macrophages is believed to repre-
sent one of the main defenses of the peritoneal cavity against
invading pathogens [5—7]. Evidence from a rat model [8] indicates
that peritoneal defense mechanisms suffice to clear invading
bacteria below a threshold level of contamination.
The CAPD technique interferes with these mechanisms in a
number of ways. Firstly, the peritoneal access facilitates the
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ingress of micro-organisms into the peritoneal cavity [9]. Also, in
vitro studies have shown that the addition of fresh dialysis fluid
adversely affects the function of resident peritoneal phagocytes
[10] and may dilute opsonins and phagocytic cells below the
concentration required for efficient phagocytosis [5, 11, 12].
Despite these observations cells in spent dialysis fluid are easily
obtained and have been the major target of studies aiming at the
delineation of the mechanisms of peritoneal defense [7].
It has been suggested recently that phagocytes "floating" free in
the dialysis fluid may not be representative of those responsible
for the defense of the peritoneal cavity in view of the low
probabilities of random interaction with invading bacteria [7, 13].
Rather, other cell populations such as those adherent to the
mesothelium or located within the peritoneal membrane and its
interstitium may be more important.
The present study was designed to investigate the distribution
of immune cells and of adhesion molecules participating in
cell-leukocyte interactions on both endothelial and mesothelial
cells in the peritoneal membrane. Our results show that the
peritoneal interstitial tissue displays an arrangement of cells that
places submesothelial macrophages in a privileged location to
meet invading micro-organisms. We found also that peritoneal
membrane blood vessels are surrounded by closely associated
macrophages and T cells suggesting engagement in activities such
as antigen presentation and/or cell activation. Moreover, besides
endothelial cells, mesothelial cells express adhesion molecules in
vivo that can provide accessory support for phagocyte and lym-
phocyte activities within the peritoneal cavity. We further inves-
tigated the distribution of leukocytes, their expression of activa-
tion markers and of adhesion molecules on endothelial and
mesothelial cell in patients on CAPD with and without peritonitis.
Methods
Patients
We studied a total of 33 individuals (Table 1): seven normal
controls, nine uremic control patients with ESRD prior to initia-
tion of peritoneal dialysis, eight on stable CAPD without clinical
evidence of peritonitis, and nine with CAPD-associated peritoni-
tis. Biopsies from this last group were taken at the moment of
catheter removal following failure of the initial antibiotic re-
gime—in all cases composed of vancomycin and a third genera-
tion cephalosporin.
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Table 1. Clinical data
Patients
Age
years
Number of
episodes of
peritonitis
Time since
last episode
of peritonitis
Time on
CAPD
months Renal disease
Normal controls (N = 7)ito 7 range (27—70) — — — —
Mean SD 52.7 16.2
Uremic controls (N = 9)
8 71 — — — IgA disease
9 59 — — — Polycystic disease
10 60 — — — Obstructive uropathy
11 22 — — — Mesangiocapillary GN
12 48 — — — Unknown etiology
13 53 — — — Reflux nephropathy
14 45 — — — Primary amyloidosis
15 61 — — — Nephrolithiasis
16 36 — — — Hypertensive nephrosclerosis
Mean SD 50.6 14.8
CAPD patients (N = 8)
17 68 1 12 m 18 Secondary amyloidosis
18 40 2 14 m 25 Chronic GN
19 60 0 — 10 LCDD
20 68 1 3 m 7 Polycystic disease
21 35 4 9 iii 39 Chronic GN
22 64 2 7 m 11 Membranous nephropathy
23 35 2 14 m 39 Chronic GN
24 45 2 4 m 29 Polycistic disease
Mean SD 51.9 14.6
Peritonitis patients (N = 9)
25 72 3 3 d 52 Hypertensive nephrosclerosis
26 67 1 4 d 53 Obstructive uropathy
27 24 5 12 d 48 Chronic GN
28 57 2 5 d 30 Crescentic GN
29 64 1 5 d 62 Unknown etiology
30 76 1 12 d 15 Diabetic nephropathy
31 28 3 4 d 13 Mesangiocapillary GN
32 72 0 8 d 3 Chronic GN
33 46 0 14 d 3 Hypertensive nephrosclerosis
Mean SD 56.2 19.4
Abbreviations are: SD, standard deviation; m, months; d, days; GN, glomerulonephritis; LCDD, light chain deposition disease.
Source of material
Biopsies of the parietal peritoneum were obtained from the
borders of anterior abdominal wall incisions during elective or
catheter-related procedures, from small hernia sacs, and from the
pelvic peritoneum during renal transplantation.
The peritoneum was carefully approached from the anteme-
sothelial side. The sample was quickly isolated with a curved
surgical clamp and cut. We tried to avoid undue manipulation,
particularly extended exposition and surgical handling, which
usually causes tissue disruption [14]. As an extra measure any
specimens with suspected sampling artifacts such as leukocyte
clogging were discarded. Care was also taken to avoid biopsying
the peritoneum around current or previous catheter entry sites.
Fragments were cut in sheets of 0.5 to 1.0 cm, oriented,
embedded in OCT compound, immediately frozen in liquid
nitrogen and stored at —70°C until processing. To allow section-
ing of some very thin membranes, peritoneal sheets were some-
times folded in two so that the mesothelial layers would face each
other. Once again, all handling was done with special caution to
avoid harm to the tissue and denudation of mesothelial cells.
Immunohistology
Glass slides were treated with an alcoholic solution of 3-ami-
nopropyltriethoxysilane to facilitate adhesion of the fragile tissue
fragments [15], without which most of the specimens floated off.
Serial vertical cryostat sections were cut at 6 to 10 jm (thinner
sections were difficult to obtain due to the loose structure of the
membrane) and fixed in acetone at 4°C for 10 minutes. Consec-
utive sections were prepared to investigate the expression of
multiple markers in the same cell population. At least two (usually
3) sections were stained with each antibody.
The indirect immunoperoxidase technique used in this study
has been described previously [16]. In brief, sections were sequen-
tially incubated with 1/5 normal rabbit serum for 10 minutes,
monoclonal antibodies (MoAbs) at appropriate dilutions (Table
2) for 90 minutes, and peroxidase-conjugated rabbit anti-mouse
IgG for 30 minutes. After the last two steps the sections were
extensively washed in phosphate-buffered saline (PBS). Slides
were then treated with 3'5'diaminobenzidine for approximately
two minutes, counter stained with Meyer's Haemalum, and
mounted in a permanent medium, In each staining session we
processed a negative control with substitution of PBS for the
primary monoclonal antibody, and positive controls for each
antibody (tonsil sections).
Study of different cell populations
Analysis was done without information about the patient
identity or clinical condition. Cells were considered positive when
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Table 2. Monoclonal antibodies employed with lespective dilutions and characteristic specificities
Antibody
______
FMC32
Leu M3
RFD7
Pan-T cocktail
UCHT 1
To15
Leu7
DK22
TFR
To5
ACT-i
6-5b5
1-2b6
i-4c3
Pal-E
Ki-67
Specificity
Monocytes; Mø; DC
Monocytes; Mø; DC
Mature tissue MØ
T cells
T cells
B cells
Natural killer cells
HLA-DR
Transferrin receptor
CR1 (C3b receptor)
IL-2 receptor
ICAM-1
ELAM-i
VCAM-1
Venules and capillaries
Proliferating cells
CD 14
CD 14
Group 12
CD 2 + 7 + 8 + 27
CD 3
CD 22
CD 56
CD 71
CD 35
CD 25
CD 54
Source
Serotec
Becton Dickinson
Royal Free Hospital
Royal Free Hospital
Dakopatts
Dakopatts
Becton Dickinson
Dakopatts
Becton Dickinson
Dakopatts
Dakopatts
Dr. D. Haskard
Dr. D. Haskard
Dr. D. Haskard
Sanbio
Dakopatts
Abbreviations are: Mø, macrophages; DC, dendritic cells.
a continuously stained plasma membrane surrounding a clearly
visible nucleus was identified. Based on preliminary studies Ieu-
kocytes were studied in the interstitium underneath the mesothe-
hal basement membrane (submesothelial area) and surrounding
peritoneal venules and capillaries (perivascular area). Their spa-
tial distribution was noted and the number of positive cells in each
area was estimated in separate and expressed according to the
following semi-quantitative scale: (0) negative; (1) rare positive
cells; (2) even distribution of small numbers and/or small clusters
of positive cells; (3) diffuse distribution of positive cells compris-
ing more than 50% of visible nuclei; and (4) positive cells forming
focal or diffuse inflammatory infiltrates.
The invariable uniform staining of venular and capillary endo-
thelium produced by the monoclonal antibody Pal-E was used as
the standard to which the staining produced by the other antibod-
ies was compared. On both endothehial and mesothelial cells, we
employed the following scale: (0) negative; (1) faint; (2) less
intense than Pal-E; (3) intensity equal to Pal-E; and (4) more
intense than Pal-E.
After the semi-quantitative scores were obtained, biopsies were
once again analyzed, this time to study the staining for the
different markers on sequential sections.
Statistical analysis
The median, mean and standard deviation of the semiquanti-
tative scores were calculated for each group of patients. The
differences in the scores among the groups were analyzed with the
Kruskall-Walhis non-parametric test. Values of P < 0.05 were
considered significant. In these cases, differences between individ-
ual groups were ascertained by performing pairwise comparisons
with the Mann-Whitney U test and the level of significance
adjusted with the Bonferroni procedure. Since the two controls
groups were considered as a single one (see below), the protection
level was set at 0.05/3 or P < 0.017. The statistical analysis was
performed on a Macintosh personal computer using the Systat
package (Systat, Inc., Evanston, Illinois, USA).
Results
Immunohistology of the peritoneal membrane in normal control
individuals and in non-dialyzed uremic patients
General architecture and distribution of cells. The general archi-
tecture and cell distribution of biopsies from normal individuals
did not differ from that of patients with renal failure prior to
initiation of peritoneal dialysis. The distribution of leukocytes, the
antigens they expressed, as well as the antigens expressed by
endothelial and mesothehial cells were also similar (Tables 3, 4, 5
and 6), and did not reach statistical significance in any of
phenotypic parameters evaluated (Mann-Whitney U test). The
description that follows (and all pairwise comparisons) apply to
the immunohistology of both groups considered as a single control
group.
The distribution of immune cells in the peritoneal tissue can be
seen in Figure la. Mesothelial cells formed a single layer of
flattened or ovoid cells with large ovoid nuclei underneath which
run a continuous basement membrane. Beneath and parallel to
the membrane, interstitial cells were arranged in rows separated
by bundles of connective tissue that comprised most of the
interstitium. Usually a short distance into the membrane lay a
capillary plexus, and often deeper in, a vascular network com-
posed of capillaries, venules and arterioles. Interstitial cells in
these areas were distributed in a concentric fashion of one or
more loose layers of cells surrounding the blood vessels.
The submesothelial interstitium.
Macrophages. Irregularly shaped cells bearing macrophage phe-
notypes, elongated and rich in cytoplasmic extensions, were
arranged in a peculiar submesothelial array. While in the deep
layers of the membrane, they followed the general pattern of cells
interspersed with connective tissue fibers; in the first layer close to
the peritoneal cavity, they formed an almost continuous sheet of
phagocytes apposed to the basement membrane. Macrophages in
this area had abundant cytoplasm spread sideways like a "fried
egg" compressed between sheets of connective tissue (Fig. 1 a and
b). These cells were usually HLA-DR and RFD7 positive. Many
also expressed ICAM-1, the complement receptor type 1 (CR1)
and, to a lesser extent, the transferrin receptor (TFR).
Lymphoid cells. Cells with B-lymphocyte (CD22) or NK cell
(CD56) phenotypes were not usually seen in the submesothelial
interstitium. T cells were scant in layers close to the peritoneal
cavity although single T cells could be found in small numbers
scattered in the deeper layers. Their pattern of distribution was
clearly different from the macrophages that concentrated imme-
diately under the mesothehial layer. Since HLA-DR and TFR
were also found on macrophages, it was impossible with the
methods used in this study to be sure whether these markers were
Phenotypes
________
Dilutions
1:40
1:20
1:40
1:10
1:40
1:40
1:40
1:20
1:10
1:20
1:10
Neat
Neat
Neat
1:20
1:20
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Table 3. Phenotypes and activation markers on submesothelial cells in peritoneal biopsies
Phenotypes & Normal controls Uremic controls CAPD patients Peritonitis patients
other markers (N = 7) (N = 9) (N = 8) (N 9) P
Mø (FMC 32) median 2.0 2.0 2.0 4.0"
mean so 1.86 0.90 2.0 0.71 1.87 0.99 3.33 0.87
MØ (Leu M3) median 2.0 1.0 1.0 2.0
mean so 1.71 0.76 1.44 0.73 1.62 1.06 2.33 1.32 NS
MØ (RFD7) median 1.0 1.0 1.0 2.0
mean SD 1.43 0.79 1.56 0.88 1.14 1.07 1.78 0.97 NS
T cells (Pan T) median 1.0 1.0' 1.0 1.0"
mean SD 0.86 0.69 1.00 0.58 0.75 0.46 1.12 0.35
T cells (UCHT 1) median 1.0 1.0 1.0 1.0
mean SD 0.86 0.69 1.00 0.50 0.62 0.52 1.11 0.33 NS
B cells (To 15) median 0.0 0.0 0.0 0.0 NSmean so 0.0 0.11 0.33 0.0 0.11 0.33
NK cells (Leu 7) median 0.0 0.0 0.0 0.0 Nmean SD 0.0 0.0 0.12 0.35 0.11 0.33
DR median 2.0 2.0 2.0 4.0"
mean so 2.14 0.69 2.22 0.44 1.87 0.99 3.33 0.87 0.008
CR1 median 1.0 1.0 1.0 1.5"
mean SD 0.86 0.64 0.89 0.78 1.71 1.13 1.62 0.74 NS
TFR median 1.0 1.0 0.0 1.0
mean SD 0.57 0.53 0.67 0.50 0.75 1.39 1.67 1.22 NS
IL-2R (TAC) median 0.0 0.0 0.0 0.0 NSmean SD 0.0 0.0 0.0 0.22 0.44
ICAM-1 median 1.0 1.0" 1.0 2.0"
mean SI) 1.00 0.00 1.12 0.35 1.00 0.535 2.22 0.97 0.002
Abbreviations are: Mø, macrophage; DR, HLA-DR; CR1, complement receptor 1; TFR, transferrin receptor; IL-2R, interleukin 2 receptor; NS =
not significant.
° Kruskall-Wallis test used for statistics
Material from one patient unavailable for analysis
C Material from two patients unavailable for analysis
dMannWhitney U test with Bonferroni correction, P < 0.017 when compared to controls
'Mann-Whitney U test with Bonferroni correction, P < 0.017 when compared to stable CAPD patients
Table 4. Phenotypes and activation markers on perivascular cells in peritoneal biopsies
Phenotypes & Normal controls Uremic controls CAPD patients Peritonitis patients
other markers (N 7) (N = 9) (N = 8) (N = 9) P
Mø (FMC 32) median 2.0 2.0 2.0 4.0" 2mean SI) 1.86 0.38 2.11 0.33 2.25 0.89 3.44 0.88
Mø (Leu M3) median 2.0 2.0 2.0 3.0
mean SD 1.57 0.53 1.67 0.71 1.75 0.71 2.67 1.12 NS
MØ (RFD7) median 2.0 1.0 1.0 2.0
mean SD 1.71 0.49 1.33 0.50 1.25 0.46 1.89 0.93
T cells (Pan T) median 2.0 2.0' 1.0 2.0"
mean SD 1.71 0.49 1.71 0.49 1.62 1.06 2.37 0.92
T cells (UCHT 1) median 2.0 1.0 1.0 2.0
mean SD 1.71 0.49 1.44 0.28 1.14 1.07 2.11 0.93
B cells (To 15) median 0.0 0.0 0.0 0.0 NSmean so 0.0 0.0 0.12 0.35 0.44 0.88
NK cells (Leu7) median 0.0 0.0 0.0 0.0 NSmean SD 0.14 0.38 0.0 0.25 0.46 0.33 0.50
DR median 2.0 2.0 2.0 4,0de
mean SD 2.29 0.49 2.11 0.33 2.25 0.89 3.67 0.71 0.001
CR1 median 1.0 1.0 1.0 i.O"
mean SD 0.71 0.76 0.89 0.60 1.12 1.25 1.50 0.53 NS
TFR median 1.0 1.0 0.0 1.0"
mean SD 0.71 0.49 0.56 0.53 0.50 1.07 1.44 0.88 0.04
IL-2R (TAC) median 0.0 0.0 0.0 0.0 NSmean SD 0,11 0.38 0.0 0.0 0.33 0.50
ICAM-1 median 1.0 1,0" 1.0 30d 002
mean SD 1.14 0.38 0.87 0.35 1.12 1.25 2.56 1.42
Abbreviations are: MØ, macrophage; DR, HLA-DR; CR1, complement receptor 1; TFR, transferrin receptor; IL-2R, interleukin 2 receptor; NS
not significant.
Kruskall-Wallis test used for statistics
Material from one patient unavailable for analysis
C Material from two patients unavailable for analysis
"Mann-Whitney U test with Bonferroni correction, P < 0.017 when compared to controls
'Mann-Whitney U test with Bonferroni correction, P < 0.017 when compared to stable CAPD patients
also expressed on isolated T cells. Except around one blood vessel
from one patient, no other cells expressing the IL-2 receptor
(IL-2R) were seen in biopsies from the two control groups.
Similarly, not a single cell in the peritoneal interstitium of the two
control groups expressed the Ki-67 marker of cell proliferation in
any biopsy.
The perivascular interstitium. A group of HLA-DR expressing
cells was always seen in close proximity to the peritoneal blood
vessels. Although the peritoneal endothelium expressed class II
antigens constitutively (see below) the staining of perivascular
cells was usually more intense. These cells did not express the
Ki-67 proliferation-associated antigen.
Macrophages and monocytes. Most of the cells surrounding
capillaries, venules and arterioles expressed the CD14 phenotype
and were HLA-DR positive (Fig. 2a). While many macrophages
expressed the RFD7 antigen, the population seemed heteroge-
neous in this regard, as some cells apparently did not express it.
Perivascular macrophages expressed CR1, TFR, and ICAM-1
with less intensity than HLA-DR. It is noteworthy that these cells
were situated in close association with blood vessels and T cells
(see below).
Lymphoid cells. Small numbers of T cells identified by the
MoAb UCHT1 (anti-CD3) and the pan T cell cocktail (mixture of
MoAbs anti-CD2, CD7, CD8, and CD27) were regularly found in
a perivascular location, particularly around venules (Fig. 2b).
Again, perivascular B cells and NK cells were practically not
found.
Endothelial cells. The immunohistochemical staining was uni-
form for all endothelial cells on a given type of vessel. In general,
for the antibodies used in this study, arterioles showed less
staining than venules and capillaries. Endothelial cells constitu-
tively presented moderate expression of HLA-DR and ICAM-1.
The staining was heavier in venules and capillaries closer to the
mesothelium than in arterioles. The adhesion molecule VCAM-1
was expressed with less intensity while the expression of ELAM- 1
was faint, if at all present.
Mesothelial cells. The immunochemical staining of mesothelial
cells was generally uniform; that is, all cells in the preparation
were either positive or negative. Mesothelial cells characteristi-
cally expressed the adhesion molecules ICAM-1, VCAM-1 and
the transferrin receptor (Fig. 3 a, b, c). ELAM-1, HLA-DR, Ki-67
or any of the other markers were not detected.
CAPD patients
The submesothelial area. In patients on CAPD without clinical
evidence of peritonitis, the continuous line of phagocytes under
the basement membrane was less evident. Also there was usually
some degree of interstitial disorganization and edema. Probably
for this reason biopsies were more difficult to cut. However, in
most patients the pattern was similar to that of controls, and the
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Table 5. Activation markers and adhesion molecules on endothelial cells in peritoneal biopsies
Phenotypes &
other markers
Normal
controls
(N = 7)
2.0
1.86 0.69
Uremic
controls
(N —9)
2.0
2.11 0.60
CAPD
patients(N = 8)
2.0
2.25 1.04
Peritonitis
patients
(N 9)
3.0c
3.22 0.83
DR median
mean SD
ICAM-1 median
mean SD
2.0
1.71 0.76
2.0"
1.62 0.52
2.0
1.75 0.46
3.0"'
2.67 0.71
VCAM-1 median
mean SD
1.0
0.86 0.69
1.0"
0.75 0.46
1.0
0.63 0.52
1.0
1.78 1.30
ELAM-1 median
mean SD
0.0
0.29 0.49
0.0"
0.12 0.35
0.0
0.38 0.74
1.OC
1.0 0.71
Abbreviations are: DR, HLA-DR; NS, not significant.aKruskall-Wallis test used for statistics
Material from one patient unavailable for analysis
C Mann-Whitney U test with Bonferroni correction, P < 0.017 when compared to controlsd
Mann-Whitney U test with Bonferroni correction, P < 0.017 when compared to stable CAPD patients
Table 6. Proliferation markers and adhesion molecules on mesothelial cells in peritoneal biopsies
P
0.02
0.0 13
NS
0.03
0.036
NS
0.045
NS
Phenotypes &
other markers
Normal
controls
(N = 7)
2.0
2.14 0.69
Uremic
controls
(N = 9)
2.0
2.11 0.60
CAPD
patients(N = 8)
10d
1,38 0.52
Peritonitis
patients
(N — 9)
1.0"
1.43 0.79
TFR median
mean sr
Ki-67 median
mean SD
0.0
0.0
0.0
0.0
0.0
0.0
0.0"
0.29 0.76
ICAM-1 median
mean SD
2.0
1.86 0.53
2.0
2.00 0.50
1.0"
1.25 0.46
1.0"
1.29 0.95
VCAM-1 median
mean SD
2.0
1.57 0.53
2.0
1.56 0.53
1.0
1.38 0.52
1.0"
1.57 0.79
Abbreviations are: TFR, transferrin receptor; NS, not significant.
a Kruskall-Wallis test used for statistics
b Material from two patients unavailable for analysis
C Staining observed in some of the cells on a multilayered mesothelial cell lining
d Mann-Whitney U test with Bonferroni correction, P < 0.017 when compared to controls
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semi-quantitative scores for macrophages and other markeTs did
not differ (Table 3), despite the impression that the cells were
apparently fewer and more dispersed within the interstitial matrix.
The perivascular area. There was no major change in the
distribution of lymphoid cells (Table 4). There was also no
statistically significant change in the perivascular macrophage
population (Table 4). However, there was a trend, supported by
the examination of consecutive slides, that a higher proportion of
immature macrophages (without RFD7 antigen expression) was
present. The expression of HLA-DR, ICAM-1, CR1 and TFR was
maintained (Table 4) although the intensity was also apparently
slightly less than that of the non-dialyzed peritoneum. Once again
these differences were not statistically significant. In one patient
(patient 20) we identified a superficial pericapillary infiltrate of
RFD7-negative macrophages with marked expression of HLADR
that disrupted the basement membrane and erupted into the
peritoneal cavity. In another area of the same biopsy there was a
dense vascular and perivascular infiltrate composed exclusively of
T cells (Fig. 4). This patient had her first episode of peritonitis
three months before the biopsy was taken.
Endothelial cells. Endothelial cells in the peritoneum of CAPD
patients did not show major changes in the expression of ICAM-1
and VCAM-1 (Table 5). The expression of HLA-DR on the
superficial capillary plexus was increased in three cases, particu-
larly in the patient with a pericapillary infiltrate. This patient also
had moderate staining for ELAM-1 on the capillaries closer to the
membrane.
Mesothelial cells. The mesothelial expression of ICAM-1 and
VCAM-1 was unchanged in CAPD patients. However, the stain-
ing for TFR was significantly lighter in comparison with the two
groups of undialyzed patients (Table 6).
CAPD patients with peritonitis
The submesothelial area. As expected, biopsies of patients with
peritonitis showed an increased number of macrophages (Table 3)
either diffusely or as focal submesothelial infiltrates. Although the
actual semi-quantitative score did not change, a greater propor-
tion of the cells were immature macrophage (RFD7 negative) as
the numbers of macrophages expressing the CD14 antigen had
increased significantly. Increased expression of HLA-DR and
ICAM-1 was also seen in association with peritonitis. In two
patients the interstitial infiltrates included cells with high endog-
enous peroxidase content, possibly polymorphonuclear leuko-
cytes. The pattern of lymphoid cells distribution in this area did
not differ from the other groups. In particular there was no
infiltration of T cells in patients with peritonitis.
The pen vascular area. Seven out of the nine patients studied had
marked perivascular leukocyte infiltrates. The cell content of
these infiltrates was heterogeneous with a predominance of
macrophages (Fig. 5a), most of them lacking the RFD7 antigen
(Fig. Sb). The majority of these cells displayed heavy expression of
HLA-DR (Fig. Sc) and moderate expression of ICAM4. The
expression of CR1 and TFR was also increased but only the latter
reached statistical significance.
The perivascular infiltrates also included T cells (Fig. 5d), a very
small proportion of which expressed the IL-2 receptor. In one
patient (patient 28) the infiltrate had the characteristics of a true
arteriolitis that included macrophages, activated T cells, B cells
and a small number of NK cells. It is interesting, and possibly
relevant, that this patient had a crescentic glomerulonephritis
diagnosed 14 years ago, and had spent a decade living with a renal
transplant and on renal replacement therapy without evidence of
active vasculitis.
Endothelial cells. Wherever perivascular infiltrates were present
a striking up-regulation on the expression of HLA-DR occurred
on endothelial cells (Fig. Sc). Endothelial cells also showed
increased expression of ICAM-1 and a light staining for ELAM-1
appeared on the superficial capillaries and venules of most
patients. The expression of VCAM-1 increased slightly but did not
change significantly.
Mesothelial cells. The mesothelial layer of patients with perito-
nitis was usually discontinuous with sheets of cells flaking away
from the membrane. The remaining cells and the bare basement
membrane were often covered with a membrane of hyaline
material. Mesothelial cells from two patients were arranged in
multiple layers interspersed with adherent leukocytes (Fig. 6). A
few cells from these patients expressed the proliferation-associ-
ated antigen recognized by MoAb Ki-67. In contrast to the
exclusive nuclear staining obtained in tonsil controls, Ki-67 pro-
duced nuclear and cytoplasmatic staining on mesothelial cells. As
in the other groups, mesothelial cells expressed VCAM-1,
ICAM-1, and TFR. Contrary to what one might expect, the
expression of these molecules did not increase with peritonitis.
Indeed, staining was significantly less for ICAM-1 and TFR.
Discussion
To date, studies of the mechanisms of peritoneal defense have
concentrated on cells obtained from the dialysate effluent, and
more recently on cultured mesothelial cells in vitro. The CAPD
technique by its very nature produces a constant depletion and/or
dilution of peritoneal fluid opsonins and phagocytes [5, 7, 11, 13].
As a consequence, their concentration in the CAPD fluid in vivo
may not be sufficient, even after reaching a more physiological pH
and osmolality, to clear invading micro-organisms in the fluid
phase of the dialysis solution [5, 12, 13]. Despite these facts, a rate
of one episode of peritonitis every nine months, nowadays con-
sidered by almost all as unacceptably high, represents on average
only one episode every 1000 exchanges. Clearly other mechanisms
must operate to account for this rather infrequent failure of the
depleted peritoneal defense.
The present study attempts, for the first time, to combine
information about peritoneal morphology with in situ character-
ization of resident and infiltrating immunocompetent cells in the
peritoneal membrane as well as their spatial relation to endothe-
hal and mesothehial cells. The initial supposition was that cells
within the membrane might also be involved in the defense
against infection. Although we have restricted our scope by
studying exclusively the parietal peritoneal membrane, the as-
sumption is that this area is representative of the participation of
immunocompetent cells in surrounding tissue in the protection of
the peritoneal cavity.
We have determined that leukocytes do not have a random
spatial distribution within the peritoneal membrane. Instead, they
display selective accumulation immediately under the mesothehial
basement membrane and around the peritoneal blood vessels. As
will be discussed below, cells from these two areas have distinct
characteristics that suggest participation in different activities.
One of the most interesting findings of this study was that
macrophages underlying the peritoneal basement membrane are
arranged in close proximity to each other, forming an almost
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continuous "first line" of cells with a phagocytic phenotype. The
CD14 differentiation antigen used in this study is probably the
best marker for cells of the mononuclear-phagocyte system, being
detected on blood monocytes and tissue macrophages with great
specificity [17]. However, CD14 is variably expressed in some
types of dendritic cells involved in antigen presentation, that also
express ICAM-1 and class II antigens [17, 181. The 77 Kd antigen
recognized by MoAb RFD7, on the other hand, is not expressed
on dendritic cells [19] but shows a strong association with the
phagocytic capability of macrophages [19, 20]. Likewise, CR1 is
useful to discriminate between these cell types, since its is also not
expressed on dendritic cells [21]. These submesothelial cells were
therefore identified as macrophages on the basis of their expres-
sion of CD14, HLA-DR, TFR, ICAM-1, CR1, and the antigen
recognized by MoAb RFD7.
We [20] and others [13] have detected large numbers of T
lymphocytes in the peritoneal fluid. These cells must originate
from the vessels that surround the peritoneal membrane. To gain
access to the peritoneal cavity they must also transit across the
endothelial layer, the perivascular and submesothelial areas and
finally the mesothelial layer. In the omentum discrete lymphoid
structures, called milky spots, are found early in life and during
peritoneal infections [22]. Although they may contribute to the
intraperitoneal T cell population, these foci of immune cells are
not usually seen in normal adults,, Despite possible differences
between omental and parietal peritoneum, T cells were seldom
seen in the submesothelial interstitium even during episodes of
peritoneal infection.
On the other hand, T cells were regularly identified in the
perivascular interstitium at the same areas where perivascular
CD 14-expressing cells also accumulated. Such proximity indicates
a potential for interaction in processes such as antigen presenta-
tion/recognition or cell activation/maturation. In fact, T cell
proliferation upon contact with macrophages has been previously
documented within the omental peritoneal tissue after intraperi-
toneal administration of antigen [23]. In keeping with this hypoth-
esis the perivascular area is the site of an intense inflammatory
reaction during peritonitis and was also encountered in one
patient on CAPD with a recent episode of peritonitis. A similar
arrangement of perivascular macrophages and T cells, the dermal
microvascular unit, which is possibly involved in antigen recogni-
tion, has been recently described in the normal human skin
[24—26].
Most of the HLA-DR-expressing perivascular cells appear to
belong to the mononuclear-phagocyte system on the basis of their
expression of CD14. These cells also stained with MoAb RFD7,
but the population seemed somewhat heterogeneous as a sizeable
proportion of the cells did not express this antigen. This was
further accentuated in patients on CAPD with or without perito-
nitis. Since we did not employ double staining methods and the
semi-quantitative index used was not suitable for detecting differ-
ences in the proportional expression of different antigens in the
same cell population, this fact became apparent only after the
examination of consecutive sections stained for these antibodies.
The phenotype of CD14-positive and RFD7-antigen-negative
macrophages is compatible with two hypotheses. The first is that
these cells may be involved in antigen presentation to perivascular
T cells rather than phagocytic activities. Another possibility is that
they may represent an immature undifferentiated monocyte pop-
ulation that has recently crossed the endothelial lining. Such an
explanation is consistent with their increased numbers in the
dialyzed peritoneum: a constant influx of blood monocytes is
expected to occur to compensate the continuous depletion of
macrophages through the dialysate. This is also in agreement with
previous reports showing that macrophages present in the effluent
of CAPD patients may show signs of immaturity when compared
to peritoneal macrophages from normal controls [6, 20].
Both in the control groups and in the CAPD patients, a greater
proportion of macrophages from the submesothelial area dis-
played the RFD7 antigen when compared to those of the perivas-
cular region. While we do not have proof, it is plausible to suppose
that they can differentiate and become activated in contact with
perivascular T cells before migrating to become incorporated into
the macrophage pool underneath the mesothelium, or even
further into the peritoneal cavity.
It may appear conceptually confusing that macrophages from
CAPD patients can experience some degree of maturation as they
leave the perivascular region and arrive at the submesothelial
area, while at the same time, immature cells are found in the
dialysis effluent [6, 20]. In a previous study [20], we have shown
that the percentage of RFD7-expressing cells increased signifi-
cantly when peritoneal macrophages from CAPD patients were
compared with blood monocytes (33.5% vs. 5.3%), although they
never reached the expression (more than 90% of the cells) found
on peritoneal macrophages from normal individuals, It is not that
mature macrophages disappear from the peritoneal cavity, just the
population becomes more heterogeneous with an increased pro-
portion of immature cells.
The results of the present study are to some extent in contrast
with studies dealing exclusively with the morphology of the
peritoneal membrane. The presence of macrophages or lympho-
cytes in the submesothelial tissue is rarely if ever mentioned either
in animal or human peritoneum [27—31]. This discrepancy is likely
to result from methodological differences. It has been said that
macrophages are difficult to identify in tissue. They are usually
scattered, can elongate or flatten and many times do not possess
readily identifiable characteristics [17]. This description fits ex-
actly with that of the peritoneal membrane macrophage. Indeed,
in our biopsy material the number of times when "empty cyto-
plasmic extensions" with macrophage phenotypes were detected
far outweighed those where a clearly identifiable nucleus could be
seen amidst the stained cytoplasm. Due to their size and mor-
phology the peritoneal macrophage covers a much wider area
than the location of the nucleus would suggest. While this fact is
probably relevant to their function, in addition it must contribute
to underestimate their frequency within the peritoneal membrane.
On the other hand, we have no explanation as to why the
T-lymphocytes so often detected in the perivascular region have
not been mentioned in previous morphological studies.
Again by analogy with the dermal microvascular unit [25, 26],
endothelial cells from the normal parietal peritoneum express
HLA-DR while resting endothelial cells are usually negative for
this antigen [32]. Class II expression is induced almost exclusively
by IFN-y, a T cell product. HLA-DR expression on endothelial
cells was clearly up-regulated during CAPD, particularly in pa-
tients with peritonitis. This provides indirect evidence for the
existence of activated T cells secreting IFN-y in the peritoneal
membrane. Yet it is not clear whether class II up-regulation on
peritoneal endothelial cells has a role in the peritoneal immune
response, or is merely an epiphenomenon of the local release of
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Fig. 3. A. Mesothelial celi expressing IcAM-] (normal control). B. Me-
sothelial cells expressing VCAM-1. The peritoneal membrane is folded
over itself so that two layers of mesothelial cells face each other (normal
control). C. Mesothelial cells expressing the transferrin receptor (uremic
control). Reproduction of this figure in color was made possible by a grant
from Baxter Healthcare Corporation, Round Lake, IL.
Fig. 6. Patient with peritonitis. Adherent HLA-DR expressing cells (ar-
rowhead), identified on sequential sections as macrophages. Cells appear
to accumulate above and below mesothelial cells arranged in multiple layers
(arrow). Intracavitary macrophages adhere to themselves as well as to
mesothelial cells. A loose amorphous material (presumably fibrin) overlays
the peritoneal membrane. Reproduction of this figure in color was made
possible by a grant from Baxter Healthcare Corporation, Round Lake, IL.
Fig. 4. Dense vascular and perivascular T cell
infiltrate in a patient with end-stage renal failure
due to polycystic kidney disease. The patient was
on CAPD for seven months and had had only
one episode of clinical peritonitis three months
before the collection of the peritoneal biopsy
(CD3 staining; UCHT1 antibody).
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Fig. 1. A. Peritoneal membrane from a normal individual stained for HLA-DR. Positive cells are identified by the precipitation of the brown end product.
An almost continuous line of positive submesothelial cells is seen underneath the mesothelium (arrow). Endothelial cells from the peritoneal blood
vessels also reacts positively (curved arrows). Non-endothelial HLA-DR-positive cells (arrowheads) are seen arranged in a concentric fashion around
blood vessels. B. Sequential section from the same area. Submesothelial cells with abundant cytoplasm and flattened appearance are identified as
macrophages on the basis of CD14 (FMC32 antibody) staining. Reproduction of this figure in color was made possible by a grant from Baxter Healthcare
Corporation, Round Lake, IL.
left — __________ ____________
Fig. 2. A. Perivascular cells belonging to the mononuclear phagocyte system expressing the CDJ4 (LeuM3 antibody) antigen in the normal peritoneal
membrane (uremic control). B. Perivascular T cells (stained with a mixture of CD2, CD7, CD8 and CD27 antibodies) in the normal peritoneal membrane
(uremic control). Reproduction of this figure in color was made possible by a grant from Baxter Healthcare Corporation, Round Lake, IL.
Top, right — __________________
Fig. 5. Serial peritoneal sections showing the perivascular infiltrate from a patient with peritonitis. The infiltrate, identified in these black and white
microphotographies by the dark end-product, is composed mainly of CD14-positive and RFD7 antigen-negative cells. A. CDI4 antigen-positive
mononuclear phagocytes stained with the FMC32 antibody (arrows). B. Few cells are stained for the RFD7 antigen (arrows). This suggests that most
of the infiltrate is composed of recently emigrated monocytes. C. Strong liLA-DR up-regulation on both perivascular macrophages and endothelial cells.
D. T cells (stained with a mixture of CD2, CD7, CD8 and CD27 antibodies) are found amidst the perivascular infiltrate (arrows).
a,
cytokines. The characterization of a putative peritoneal microvas-
cular unit involved in antigen recognition and cell-mediated
immune response clearly merits further investigation.
The normal peritoneal endothelium also display moderate
expression of the adhesion molecules ICAM-1 and VCAM-1.
These cell surface molecules are involved in the adhesion of
phagocytes and lymphocytes to endothelial surfaces and mediate
cell extravasation during the inflammatory response where their
expression is induced by a number of cytokines [33]. Their
presence on the peritoneal microvasculature may at least in part
account for the replenishment of immunocompetent cells contin-
uously lost in the peritoneal dialysate. The up-regulation of these
molecules in cases of peritonitis is consistent with this hypothesis.
Another adhesion molecule, ELAM-1—which mediates the
binding of granulocytes to acutely inflamed endothelium [33]—
was not present on endothelial cells from normal peritoneal
membrane and only became lightly expressed in those cases with
perivascular inflammation, The fact that our biopsies were taken
at a relatively late phase of the infection may account for this fact
as well as the rarity of neutrophils in patients with peritonitis.
Accordingly, neutrophils within the peritoneal membrane were
only identified in two of the cases showing ELAM-1 expression on
endothelial cells. A recent report documents the participation of
ELAM—1 in the binding of resting memory T cells to IL-i induced
endothelium [34]. The light expression detected in our patients
may not have any relevance regarding cell-mediated responses,
but it is tempting to speculate a role for ELAM-1 in the
recruitment of memory T cells during peritoneal inflammation.
Normal mesothelial cells showed intense staining for the trans-
ferrin receptor, a finding that to our knowledge has not been
described previously. Typically the TFR is expressed by cells in the
process of multiplication [35]. However, the MoAb Ki-67 that
recognizes an antigen present on the nuclei of proliferating cells
[36] did not stain a single cell in the normal mesothelium. There
was no evidence of a proliferative response by mesothelial cells, in
the resting peritoneum, to explain their transferrin receptor
expression. Ki-67 staining was found on mesothelial cells of only
two patients with peritonitis. In these cases staining was localized
to areas where mesothelial cells were arranged in multiple layers,
displayed double nuclei and were, therefore, obviously undergo-
ing active regeneration. Cells from these areas also strongly
expressed the TFR. Hence, the intense TFR expression on
mesothelial cells may have some other physiological role, and it is
interesting that, apart from those patients with an actively regen-
erating mesothelium, TFR expression diminishes in most patients
with peritonitis.
In contrast to cultured mesothelial cells [37], no HLA-DR
expression was found on our biopsy material, even in those cases
with ongoing peritonitis and strong up-regulation of this class II
antigen on both endothelial cells and peritoneal macrophages
(Fig. 6). However, we were able to detect the in vivo constitutive
expression of the adhesion molecules ICAM-1 and VCAM-l on
mesothelial cells. Although the expression of these adhesion
molecules has been reported on mesothelial cells in culture [37],
the classical description of the tissue distribution of ICAM-1 does
not mention this finding [38]. This is somewhat surprising as
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Floating macrophages
and lymphocytes
Mesothelial cells
Adherent phagocytes
and lymphocytes
Submesothelial macrophages
Perivascular macrophages and T-cells
Fig. 7. Proposed spatial distribution of immune cells in the peritoneal membrane and within the peritoneal cavity.
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samples of liver and intestine were studied and these organs have
a mesothelial lining on the external surface. In contrast, a recent
publication studying VCAM-1 does mention its expression on
mesothelial cells of the liver peritoneum [39].
ICAM-1 is a counter-receptor for the 132 integrin LFA-1
(CD11a/CD18) expressed on all leukocytes [40]. The interaction
of ICAM-1 and LFA-1 provides accessory support to many
lymphocyte and phagocyte interactions including antigen recog-
nition and endothelial cell binding [33, 40]. Similarly, VCAM-1
through binding to the 13 integrin VLA-4 also functions as an
accessory molecule for lymphocyte and monocyte interactions
with endothelial cells [33, 40].
It is reasonable to suppose that ICAM-1-LFA-1 and VCAM-
1-VLA-4, and other as yet not identified pairs of surface mole-
cules, are able to mediate lymphocyte and phagocyte binding to
the mesothelial surface. In this manner, interactions between
peritoneal cells would be able to proceed independently of the
random collision of floating cells in the peritoneal fluid. Indeed,
the encounter of phagocytes and bacteria upon tissue surfaces
may be associated with more efficient phagocytosis, a fact previ-
ously shown in vivo on endothelial surfaces [41] and in vitro on
cultured mesothelial cells [42].
More than 20 years ago, a microcinematographic study in mice
described two different types of macrophages in the omental
peritoneum: a submesothelial tissue bound dendritic cell, and a
free, round or stellate cell that wanders on the surface of the
peritoneal membrane [23]. In addition, leukocytes bound to the
normal mice mesothelium have been demonstrated in a study
where in situ fixation of the peritoneal membrane was employed
[43]. More recently, monocytes have been shown to adhere to
cultured human mesothelial cells, particularly after cytokine stim-
ulation of either cell type, in a process where the adhesion
molecules ICAM-1 and VCAM-1 and their ligands participate
[37].
In spite of the suggestive evidence, the existence of leukocytes
adherent to the normal human peritoneal membrane is still
speculative. Adhesion may be weak under normal circumstances
and, as such, unable to resist the handling required for harvesting
and processing the peritoneal biopsy. Indeed, mesothelial cells,
even with the support provided by their basement membrane, are
particularly susceptible to detachment, unless the biopsy is col-
lected with extreme care [14]. On the other hand, adherent cells
are much easier to demonstrate during experimental [43, 44] and
clinical peritonitis (Fig. 6) [44]. During acute peritonitis, not only
leukocyte numbers are increased, but also up-regulation or acti-
vation of adhesion molecules on both cell types is likely to occur
and prevent their detachment from one another.
In conclusion, in addition to mononuclear cells dispersed in the
peritoneal fluid, we have shown the existence of two distinct
peritoneal membrane leukocyte populations: the submesothelial
macrophage and the perivascular unit composed of macrophages
and T cells. We further show the constitutive expression of
adhesion molecules on mesothelial cells in vivo, which suggests
that intracavitary adherent leukocytes may also participate in the
defense of the peritoneum. These four groups of immune cells
and their histological localization are depicted in Figure 7. The
investigation of the role of these different cells types should help
to elucidate the mystery still posed by the peritoneal defense
against invading microorganisms.
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